These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 34676830)
21. Decreased Axon Caliber Underlies Loss of Fiber Tract Integrity, Disproportional Reductions in White Matter Volume, and Microcephaly in Angelman Syndrome Model Mice. Judson MC; Burette AC; Thaxton CL; Pribisko AL; Shen MD; Rumple AM; Del Cid WA; Paniagua B; Styner M; Weinberg RJ; Philpot BD J Neurosci; 2017 Aug; 37(31):7347-7361. PubMed ID: 28663201 [TBL] [Abstract][Full Text] [Related]
22. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. Meng L; Ward AJ; Chun S; Bennett CF; Beaudet AL; Rigo F Nature; 2015 Feb; 518(7539):409-12. PubMed ID: 25470045 [TBL] [Abstract][Full Text] [Related]
23. Functional rescue in an Angelman syndrome model following treatment with lentivector transduced hematopoietic stem cells. Adhikari A; Copping NA; Beegle J; Cameron DL; Deng P; O'Geen H; Segal DJ; Fink KD; Silverman JL; Anderson JS Hum Mol Genet; 2021 Jun; 30(12):1067-1083. PubMed ID: 33856035 [TBL] [Abstract][Full Text] [Related]
24. Gene Therapy for Angelman Syndrome: Contemporary Approaches and Future Endeavors. Tsagkaris C; Papakosta V; Miranda AV; Zacharopoulou L; Danilchenko V; Matiashova L; Dhar A Curr Gene Ther; 2020; 19(6):359-366. PubMed ID: 31914913 [TBL] [Abstract][Full Text] [Related]
25. Abundance and localization of human UBE3A protein isoforms. Sirois CL; Bloom JE; Fink JJ; Gorka D; Keller S; Germain ND; Levine ES; Chamberlain SJ Hum Mol Genet; 2020 Nov; 29(18):3021-3031. PubMed ID: 32833011 [TBL] [Abstract][Full Text] [Related]
26. Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model. Meng L; Person RE; Huang W; Zhu PJ; Costa-Mattioli M; Beaudet AL PLoS Genet; 2013; 9(12):e1004039. PubMed ID: 24385930 [TBL] [Abstract][Full Text] [Related]
27. CRISPR/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice. Schmid RS; Deng X; Panikker P; Msackyi M; Breton C; Wilson JM J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33411694 [TBL] [Abstract][Full Text] [Related]
32. Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant Lee HM; Clark EP; Kuijer MB; Cushman M; Pommier Y; Philpot BD Mol Autism; 2018; 9():45. PubMed ID: 30140420 [TBL] [Abstract][Full Text] [Related]
33. Changes in mGlu5 receptor-dependent synaptic plasticity and coupling to homer proteins in the hippocampus of Ube3A hemizygous mice modeling angelman syndrome. Pignatelli M; Piccinin S; Molinaro G; Di Menna L; Riozzi B; Cannella M; Motolese M; Vetere G; Catania MV; Battaglia G; Nicoletti F; Nisticò R; Bruno V J Neurosci; 2014 Mar; 34(13):4558-66. PubMed ID: 24672001 [TBL] [Abstract][Full Text] [Related]